SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析

◆英語タイトル:SalvaRx Group plc (SALV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14798
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipeline which anti-cancer treatments based on iNKT cells under license from the Ludwig Institute for cancer research. The company offers acquisition of immune-oncology therapeutics which complementary to anti-PD1 or anti-PDL1 therapies. It operates in Northern Poland and the UK. SalvaRx is headquartered in Ramsey, the UK.

SalvaRx Group plc Key Recent Developments

Sep 27,2018: SalvaRx Group: Half Yearly Report to 30 June 2018
Jun 28,2018: SalvaRx Group Announces Final Results
Mar 08,2018: SalvaRx: business update of March 2018

This comprehensive SWOT profile of SalvaRx Group plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of SalvaRx Group plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

SalvaRx Group plc – Key Information
SalvaRx Group plc – Overview
SalvaRx Group plc – Key Employees
SalvaRx Group plc – Key Employee Biographies
SalvaRx Group plc – Key Operational Heads
SalvaRx Group plc – Major Products and Services
SalvaRx Group plc – History
SalvaRx Group plc – Company Statement
SalvaRx Group plc – Locations And Subsidiaries
SalvaRx Group plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

SalvaRx Group plc – Business Description
SalvaRx Group plc – Corporate Strategy
SalvaRx Group plc – SWOT Analysis
SWOT Analysis – Overview
SalvaRx Group plc – Strengths
SalvaRx Group plc – Weaknesses
SalvaRx Group plc – Opportunities
SalvaRx Group plc – Threats
SalvaRx Group plc – Key Competitors

Section 3 – Company Financial Performance Charts

SalvaRx Group plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

SalvaRx Group plc, Key Information
SalvaRx Group plc, Key Ratios
SalvaRx Group plc, Share Data
SalvaRx Group plc, Major Products and Services
SalvaRx Group plc, History
SalvaRx Group plc, Key Employees
SalvaRx Group plc, Key Employee Biographies
SalvaRx Group plc, Key Operational Heads
SalvaRx Group plc, Other Locations
SalvaRx Group plc, Subsidiaries
SalvaRx Group plc, Key Manufacturing facilities
SalvaRx Group plc, Key Competitors
SalvaRx Group plc, SWOT Analysis
SalvaRx Group plc, Ratios based on current share price
SalvaRx Group plc, Annual Ratios
SalvaRx Group plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

SalvaRx Group plc, Performance Chart
SalvaRx Group plc, Ratio Charts

★海外企業調査レポート[SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kennametal Inc.:企業の戦略・SWOT・財務分析
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Telephone and Data Systems, Inc.:企業の戦略・SWOT・財務情報
    Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Telephone and Data Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • OncoSil Medical Ltd (OSL)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務情報
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nine Dragons Paper (Holdings) Limited:戦略・SWOT・企業財務分析
    Nine Dragons Paper (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Caisse de depot et placement du Quebec:企業のM&A・事業提携・投資動向
    Caisse de depot et placement du Quebec - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Caisse de depot et placement du Quebec Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Sv. Sv. Konstantin I Elena Holding Ad:企業の戦略・SWOT・財務分析
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • GATC Biotech AG-製薬・医療分野:企業M&A・提携分析
    Summary GATC Biotech AG (GATC Biotech) is a healthcare service center that offers sequencing services. The center products category include nextgen, liquid biopsy, tissue biopsy, sanger and cell culture. It offers nextgen products such as inview transcriptome, inview metagenome, inview microbiome, i …
  • OSI Systems, Inc. (OSIS):企業の財務・戦略的SWOT分析
    OSI Systems, Inc. (OSIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SFL Corp Ltd (SFL):企業の財務・戦略的SWOT分析
    Summary SFL Corp Ltd (SFL) is engaged in providing bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible, dry bulk carriers and drilling rigs, among others. In addition, it also operates car carriers, of …
  • Eureka Forbes Limited:企業の戦略的SWOT分析
    Eureka Forbes Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ipsos SA (IPS):企業の財務・戦略的SWOT分析
    Ipsos SA (IPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • New Zealand Oil & Gas Ltd (NZO):石油・ガス:M&Aディール及び事業提携情報
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Cypress Semiconductor Corporation (CY):企業の財務・戦略的SWOT分析
    Cypress Semiconductor Corporation (CY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Hindustan Construction Co. Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co. Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fair Isaac Corp (FICO):企業の財務・戦略的SWOT分析
    Fair Isaac Corp (FICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • IMPACT Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary IMPACT Therapeutics Inc (IMPACT) is a developer of therapeutics to treat cancer and other life-threatening diseases. The company provides products such as microtubule inhibitors, PARP-1 inhibitors, and Hedgehog pathway inhibitors for oncology. Its PARP-1 inhibitor is an oral bioavailability; …
  • Crown Castle International Corp (CCI):企業の財務・戦略的SWOT分析
    Crown Castle International Corp (CCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆